AFFY  Affymax Inc.

Exchange

NASDAQ

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

24.0M

Vuru Grade

50.88/100

Current Price

$0.64
0.00 (0.00%)

Company Metrics

  • 0 P/E
  • 17.53 P/S
  • 103.33 P/B
  • -0.385 EPS
  • -2,418.60% Cash ROIC
  • 4.98 Cash Ratio
  • 0 / 0% Dividend
  • 220,403.00 Avg. Vol.
  • 33.29M Shares
  • 24.0M Market Cap.

Company Description

Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. The company is developing Hematide, which is in Phase III clinical trials for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood ...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.